Kasper Roet retweeted
QurAlis presents! CEO & founder @RoetKasper recently presented a corporate overview and update at the Piper Sandler 35th Annual Healthcare Conference. #ALS #FTD #precisionmedicine #neurodegenerativediseases
Kasper Roet retweeted
QurAlis' CEO and founder @RoetKasper was an invited speaker on the 2023 William Blair Innovator Series: Genetic Medicines panel, "Combining Novel Genetics and Modalities to Tackle Neurodegenerative Disorders." #ALS #precisionmedicine #neurodegenerativediseases
Kasper Roet retweeted
QurAlis presents! Vikas Sharma, QurAlis' chief business officer, recently presented a corporate update at the #BioFuture2023 conference. #ALS #precisionmedicine #neurodegenerativediseases
Kasper Roet retweeted
Our CEO and founder @RoetKasper (r) led a Termeer Foundation fireside chat with @MIT professor Jonathan Fleming (l), QurAlis advisor, early investor & former board chair, and Kristina Masson, CEO of Acrivon AB. #ALS #precisionmedicine #neurodegenerativediseases
Kasper Roet retweeted
This photo is from October 2017. Two months after I was diagnosed with ALS.
On the outside, I look normal but on the inside, I was spinning with questions and uncertainty about my future.
Kasper Roet retweeted
QurAlis at #ENCALS23! QurAlis' chief medical officer @genge_angela moderated the Therapeutic Session. #ALS #precisionmedicine #neurodegenerativediseases
Kasper Roet retweeted
QurAlis at #ENCALS23! Clinical team members @KristianaSalmon and @ClaridaMartinez presented a poster on our QRL-201 ANQUR clinical trial - the 1st-ever study to evaluate a therapy that rescues #STMN2 expression in #ALS patients. #precisionmedicine #neurodegenerativediseases
Kasper Roet retweeted
QurAlis is proud to sponsor #ENCALS23. Wishing all a most successful meeting as we work toward conquering #ALS and other #neurodegenerativediseases. #precisionmedicine bit.ly/3rjUQ8p
Kasper Roet retweeted
One of the great moments during our @biolabs opening in #Paris this week @HotelDieuParis
Meeting Jérôme Monceaux, the inspiring founder of @EnchantedTools and their creation #Mirokai, an animated character/#robot for healthcare applications, together with minister @sretailleau
Kasper Roet retweeted
QurAlis in the news! Excited to have QurAlis and our CEO and co-founder @RoetKasper featured in the @NatureBiotechnology article about #ALS drug development and biomarkers. #precisionmedicine #neurodegenerativediseases bit.ly/44gM3mg
Kasper Roet retweeted
QurAlis is excited to announce a collaboration with @UnlearnAI to accelerate and optimize our clinical program in #ALS with Unlearn's advanced generative #AI technology. Read more here bit.ly/3pql7RP #precisionmedicine #neurodegenerativediseases
Kasper Roet retweeted
👇🏽
“Soooo you mean to tell me that someone down your ancestry line survived being chained to other human bodies for several months in the bottom of a disease-infested ship during the Middle Passage, lost their language, customs and traditions, picked up the English language as best they could while working free of charge from sunup to sundown as they watched babies sold from out of their arms and women raped by ruthless slave owners.
Took names with no last names, no birth certificates, no heritage of any kind, braved the Underground Railroad, survived the Civil War to enter into sharecropping... Learned to read and write out of sheer will and determination, faced the burning crosses of the KKK, everted their eyes at the black bodies swinging from ropes hung on trees... Fought in World Wars as soldiers to return to America as boys, marched in Birmingham, hosed in Selma, jailed in Wilmington, assassinated in Memphis, segregated in the South, ghettoed in the North, ignored in history books, stereotyped in Hollywood... and in spite of it all someone in your family line endured every era to make sure you would get here and you receive one rejection, face one obstacle, lose one friend, get overlooked, and you want to quit? How dare you entertain the very thought of quitting. People, you will never know survived from generation to generation so you could succeed. Don’t you dare let them down!
Give this to your young people who don’t know their history and want to get weak!
It is NOT in our DNA to quit!”
Kasper Roet retweeted
QurAlis soon could extend its ALS Phase 1 safety trial of QRL-201 in countries including in Germany, Belgium, the Netherlands, and Ireland. buff.ly/3NctVCE
#ALS #ALSNewsToday #amyotrophiclateralsclerosis #livingwithALS #ALSresearch
Kasper Roet retweeted
Our CEO & founder @RoetKasper (2nd fr r) in “The Innovation Gap: Dissecting Emerging Modalities and Mechanisms for Treating CNS Diseases” panel today at @MassGenBrigham #WMIF2023 hosted by @MGBInnovation presented by @BofA_News. #ALS #precisionmedicine #neurodegenerativediseases
Kasper Roet retweeted
QurAlis' CMO @genge_angela delivering one of four presentations at the @CNSFNeurolinks annual meeting 2023 in Banff. #ALS #precisionmedicine #neurodegenerativediseases
Kasper Roet retweeted
Tonight I want to put this into the world and see what happens:
I hope that you had a great day, are with people you love, are doing something you love, or are just celebrating being here.
Good night moon.
Kasper Roet retweeted
Thank you to conference sponsor @QurAlisCo for your ongoing support of #LongwoodHealthcareLeaders. We’re thrilled to host @RoetKasper as he discusses advances in #neurosciences at @MIT.
Kasper Roet retweeted
We're honored to share that @genge_angela, QurAlis' CMO, has been named the first international recipient of the @MDAorg Wings Over Wall Street Diamond Award. This award is given annually to a scientific leader dedicated to the eradication of #ALS. bit.ly/43sjBgD
Kasper Roet retweeted
Our CSO Dan Elbaum recently presented on QRL-201, one of QurAlis' lead programs in #ALS at the 2023 #TargetALS conference. Dan's talk was entitled, "QRL-201: A #Stathmin-2 Splice-switching #ASO." #precisionmedicine #neurodegenerativediseases
Kasper Roet retweeted
The first patient has been dosed in a Phase 1 clinical trial testing the viability of QRL-201 for treating #ALS. The experimental therapy increases production of stathmin-2, a protein neeeded for neuronal growth and repair. buff.ly/43UkFuE
#amyotrophiclateralsclerosis























